Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Interventional Phase 1b, Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacodynamic Effect of PF-07258669 Compared to Placebo in Older Participants Including Those at Risk of Malnutrition

NCT07086664 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT07086664
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07086664 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Interventional Phase 1b, Randomized, Double-Blind, Sponsor-Open, Placebo-Controlled Study to Investigate the Safety, Tolerability, and Pharmacodynamic Effect of PF-07258669 Compared to Placebo in Older Participants Including Those at Risk of Malnutrition
Lead sponsor
Pfizer
Phase
Phase 1
Overall status
Terminated
Start date
August 5, 2025
Completion date
January 21, 2026
Enrollment
7 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers